ResearcherNanjing Medical UniversityActive in the last 2 years

Zhenyu Li

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

An Insulin-Exosome-TNFAIP8 Axis Drives Stromal Fibrosis and Therapeutic Resistance in Pancreatic Cancer. Co-author DOI 10.1002/advs.202515606 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tao Wang · 1 shared paper, 2026 · strength 0.24
- Paper An Insulin-Exosome-TNFAIP8 Axis Drives Stromal Fibrosis and Therapeutic Resistance in Pancreatic Cancer. DOI 10.1002/advs.202515606 ↗
Lingdi Yin · 1 shared paper, 2026 · strength 0.24
- Paper An Insulin-Exosome-TNFAIP8 Axis Drives Stromal Fibrosis and Therapeutic Resistance in Pancreatic Cancer. DOI 10.1002/advs.202515606 ↗
Chunhua Xi · 1 shared paper, 2026 · strength 0.24
- Paper An Insulin-Exosome-TNFAIP8 Axis Drives Stromal Fibrosis and Therapeutic Resistance in Pancreatic Cancer. DOI 10.1002/advs.202515606 ↗
Yi Miao · 1 shared paper, 2026 · strength 0.24
- Paper An Insulin-Exosome-TNFAIP8 Axis Drives Stromal Fibrosis and Therapeutic Resistance in Pancreatic Cancer. DOI 10.1002/advs.202515606 ↗
Jun Yu · 1 shared paper, 2026 · strength 0.24
- Paper An Insulin-Exosome-TNFAIP8 Axis Drives Stromal Fibrosis and Therapeutic Resistance in Pancreatic Cancer. DOI 10.1002/advs.202515606 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.